Healthcare
April 23, 2018 / 4:52 AM / 10 months ago

BRIEF-Relief Therapeutics Grants Option To License Aviptadil To Seren Clinical

1 Min Read

April 23 (Reuters) - RELIEF THERAPEUTICS Holding SA:

* ANNOUNCES THAT IT HAS GRANTED AN OPTION TO LICENSE AVIPTADIL TO SEREN CLINICAL

* PRE-NEGOTIATED FINANCIAL TERMS OF PUTATIVE FUTURE LICENSING AGREEMENT NOT DISCLOSED Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below